Trending Now
Cassava Sciences Inc. (NASDAQ: SAVA) Releases Clinical Data On Simufilam In...
Cassava Sciences Inc. (NASDAQ: SAVA) has announced top-line clinical study data from its pre-planned interim analysis of the ongoing open-label trial with simufilam in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Oncolytics Biotech Inc. (NASDAQ:ONC) Reports AWARE-1 data showing That Pelareorep Primes...
Oncolytics Biotech Inc. (NASDAQ:ONC) has announced that it has published clinical data from its AWARE-1 early breast cancer trial in an e-poster. The company...
MAKE IT MODERN
LATEST REVIEWS
Black Diamond Therapeutics Inc. (NASDAQ:BDTX) Announces Fast Track Designation to BDTX-189...
There are hundreds of adult patients under the affliction of solid tumors harboring an allosteric HER2 mutation or an EGFR or HER2 exon 20...
MAKE IT MODERN
PERFORMANCE TRAINING
TRACON Pharmaceuticals (NASDAQ:TCON) Reports Study Results Of Envafolimab In MSI-HdMMR Colorectal Cancer
TRACON Pharmaceuticals (NASDAQ:TCON) has released updated clinical results from its pivotal envafolimab study in MSI-H/dMMR cancer patients. TRACON’s corporate partners Alphamab Oncology and 3D...
Affimed NV (NASDAQ: AFMD) Reports A Stellar Growth Of 129.41% In Q1 2021 Revenues...
Affimed NV (NASDAQ: AFMD) posted revenues of Euro 11.7 million (up 129.41% YoY) in Q1 2021, mainly from the collaboration with Roivant and Genentech.
Its...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Announces New Preclinical Data Showing STI-9199’s Potential in Preventing...
Sorrento Therapeutics Inc. (NASDAQ: SRNE) has announced new preclinical findings showing that pretreating animal models with intranasal neutralizing antibody (STI-9199) 24 hours before being...
Seelos Therapeutics Inc. (NASDAQ:SEEL) Granted Patent For SLS-002 By Japanese Patent Office And SLS-005...
Seelos Therapeutics Inc. (NASDAQ:SEEL) has announced that the Japanese patent Office has issued it with a patent (patent number 6722453) that covers SLS-002.
Seelos receives...
Tiziana (NASDAQ:TLSA) Submits a Patent Application on Potential Use of Foralumab for Improvement of...
Tiziana (NASDAQ:TLSA) has what it takes to offer cancer patients non-intravenous treatment. The company has been doing a phenomenal job in the development of...
MAKE IT MODERN
